SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-006419
Filing Date
2020-01-13
Accepted
2020-01-13 17:30:09
Documents
14
Period of Report
2020-01-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d866797d8k.htm   iXBRL 8-K 31627
2 EX-99.1 d866797dex991.htm EX-99.1 21463
6 GRAPHIC g866797g0113221819986.jpg GRAPHIC 4071
  Complete submission text file 0001193125-20-006419.txt   188046

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gwph-20200112.xsd EX-101.SCH 3041
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gwph-20200112_lab.xml EX-101.LAB 18063
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gwph-20200112_pre.xml EX-101.PRE 11356
8 EXTRACTED XBRL INSTANCE DOCUMENT d866797d8k_htm.xml XML 3478
Mailing Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000
Business Address SOVEREIGN HOUSE VISION PARK HISTON, CAMBRIDGE CB24 9BZ X0 00000 44 1223 266800
GW PHARMACEUTICALS PLC (Filer) CIK: 0001351288 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35892 | Film No.: 20524508
SIC: 2834 Pharmaceutical Preparations